Association of Placental Mesenchymal Dysplasia With a Live Female Fetus and Complete Hydatidiform Mole: Report of a Challenging Case Confirmed by Molecular Genotyping Analysis

Int J Gynecol Pathol. 2022 May 1;41(3):251-257. doi: 10.1097/PGP.0000000000000786. Epub 2021 Apr 1.

Abstract

Placental mesenchymal dysplasia (PMD) and complete hydatidiform mole (CHM) with a coexisting fetus are 2 rare placental abnormalities characterized by lacunar placenta and presence of an embryo on ultrasound examination. We report the case of a 34-yr-old woman referred at 32.6 weeks of gestation because of a multicystic placenta. A caesarean section was performed at 39.1 weeks of gestation giving birth to a 2905 g normal female infant. Pathological examination revealed macroscopic and microscopic morphological, and immunohistological features of PMD in the main placenta, and features of CHM in a separate placental mass. Fluorescent in situ hybridization and molecular genotyping analyses showed diandric diploidy in the CHM component and androgenetic/biparental mosaicism in the PMD component, confirming the association of PMD and CHM with a live infant. There was no progression to gestational trophoblastic neoplasia during follow-up for the mother, or any sign of Beckwith-Wiedemann syndrome or hepatic tumor in the child.

Publication types

  • Case Reports

MeSH terms

  • Cesarean Section
  • Child
  • Female
  • Fetus / pathology
  • Genotype
  • Humans
  • Hydatidiform Mole* / pathology
  • Hyperplasia / pathology
  • In Situ Hybridization, Fluorescence
  • Placenta / pathology
  • Placenta Diseases* / pathology
  • Pregnancy
  • Uterine Neoplasms* / pathology